명태(Theragra chalcogramma) 껍질 유래 젤라틴 가수분해물의 항 HIV-1 효능 = Anti-HIV-1 Activity of Gelatin Hydrolysate Derived from Alaska Pollack Theragra chalcogramma Skin

다국어 초록 (Multilingual Abstract)

Infection with HIV [Human immunodeficiency virus], over time, develops into acquired immunodeficiency syndrome (AIDS). The development of non-toxic and effective anti-HIV drugs is one of the most promising strategies for the treatment of AIDS. In this study, we investigated the anti-HIV-1 activity of gelatin hydrolysates from Alaska pollack skin. Gelatin hydrolysates were prepared using four enzymes (alcalase, flavourzyme, neutrase, and pronase E).
Among these, the pronase E gelatin hydrolysate was found to inhibit HIV-1 infection in the human T cell-line MT4. It exhibited inhibitory activity on HIV-1IIIB-induced cell lysis, reverse transcriptase activity, and viral p24 production at noncytotoxic concentrations. Moreover, it decreased the activation of matrix metalloproteinase-2 (MMP-2) in vitro.
Because HIV infection-induced activation of MMP-2 can accelerate collagen resolution and collapse of the immune system, pronase E gelatin hydrolysate might prevent the activation of MMP-2 in cells, resulting in collagen stabilization and immune cell homeostasis consistent with anti-HIV activation. These results suggest that pronase E gelatin hydrolysate could potentially be incorporated into a novel therapeutic agent for HIV/AIDS patients.

참고문헌 (Reference)

1 안용석, "옥돔(Branchiostegus japonicus) 비늘 유래 젤라틴의 가수분해 및 가수분해물의 기능성" 한국수산과학회 42 (42): 417-425, 2009

2 허민수, "명태 수리미 부산물 유래 젤라틴 가수분해물을 이용한 시판 간장의 항산화성 및 ACE 저해활성의 개선" 한국수산과학회 43 (43): 179-187, 2010

3 Korea Federation for HIV/AIDS prevention, "www.kaids.or.kr/main"

4 Jacob D. Estes, "The role of collagen deposition in depleting CD4+ T cells and limiting reconstitution in HIV-1 and SIV infections through damage to the secondary lymphoid organ niche" Elsevier BV 20 (20): 181-186, 2008

5 Rebecca L Kusko, "Premature expression of a muscle fibrosis axis in chronic HIV infection" Springer Nature 2 (2): 10-, 2012

6 Claudio M. Mastroianni, "Matrix metalloproteinase dysregulation in HIV infection: implications for therapeutic strategies" Elsevier BV 13 (13): 449-459, 2007

7 R. Gallo, "Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS)" American Association for the Advancement of Science (AAAS) 220 (220): 865-867, 1983

8 F Barre-Sinoussi, "Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)" American Association for the Advancement of Science (AAAS) 220 (220): 868-871, 1983

9 Martin Ruehl, "Hydroxyproline-containing collagen analogs trigger the release and activation of collagen-sequestered proMMP-2 by competition with prodomain-derived peptide P33-42" Springer Nature 4 (4): 33-42, 2011

10 Angela Zampella, "Homophymine A, an anti-HIV cyclodepsipeptide from the sponge Homophymia sp" American Chemical Society (ACS) 73 (73): 5319-5327, 2008

11 Alba Diaz, "Factors associated with collagen deposition in lymphoid tissue in long-term treated HIV-infected patients" Ovid Technologies (Wolters Kluwer Health) 24 (24): 2029-2039, 2010

12 Susan Kasedde, "Executive Summary" Ovid Technologies (Wolters Kluwer Health) 66 : S139-S143, 2014

13 Karen Anderson, "Developing Novel Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors: Beyond the Butterfly" Bentham Science Publishers Ltd. 12 (12): 1857-1865, 2006

14 Alberto Plaza, "Celebesides A−C and Theopapuamides B−D, Depsipeptides from an Indonesian Sponge That Inhibit HIV-1 Entry" American Chemical Society (ACS) 74 (74): 504-512, 2009